Regulations Amending Certain Regulations Made Under the Financial Administration Act (Controlled Substances): SOR/2025-245

Canada Gazette, Part II, Volume 159, Number 26

Registration
SOR/2025-245 November 28, 2025

FINANCIAL ADMINISTRATION ACT

P.C. 2025-843 November 28, 2025

Her Excellency the Governor General in Council, on the recommendation of the Treasury Board and the Minister of Health, makes the annexed Regulations Amending Certain Regulations Made Under the Financial Administration Act (Controlled Substances) under subsection 19(1)footnote a and section 19.1footnote a of the Financial Administration Act footnote b.

Regulations Amending Certain Regulations Made Under the Financial Administration Act (Controlled Substances)

Licensed Dealers for Controlled Drugs and Narcotics (Veterinary Use) Fees Regulations

1 The definitions controlled drug, dealer’s licence and narcotic in section 1 of the Licensed Dealers for Controlled Drugs and Narcotics (Veterinary Use) Fees Regulationsfootnote 1 are replaced by the following:

controlled drug
has the same meaning as in subsection 1(1) of the Controlled Substances Regulations. (drogue contrôlée)
dealer’s licence
means a licence issued under subsection 12(1) of the Controlled Substances Regulations and that relates to a controlled drug or narcotic. (licence de distributeur autorisé)
narcotic
has the same meaning as in subsection 1(1) of the Controlled Substances Regulations. (stupéfiant)

Fees in Respect of Dealer’s Licences Regulations

2 The Fees in Respect of Dealer’s Licences Regulationsfootnote 2 are amended by adding the following before section 2:

Definitions

1 (1) The following definitions apply in these Regulations.

dealer’s licence
means a licence issued under subsection 12(1) of the Controlled Substances Regulations in relation to a controlled drug or narcotic, as those terms are defined in subsection 1(1) of those Regulations. (licence de distributeur autorisé)
health care facility
means a facility that provides diagnostic or therapeutic services to patients. It includes a group of such facilities that report to one common management that is responsible for their activities. (établissement de santé)

Words and expressions

(2) Unless the context otherwise requires, all other words and expressions used in sections 30, 31 and 33 have the same meaning as in the Controlled Drugs and Substances Act or the Controlled Substances Regulations.

3 Subsection 2(1) of the Regulations is replaced by the following:

Purpose — fees

2 (1) The purpose of these Regulations is to prescribe the fees for the examination of an application submitted under section 11 or 15 of the Controlled Substances Regulations for the issuance or renewal of a dealer’s licence in relation to a controlled drug or narcotic, as those terms are defined in subsection 1(1) of those Regulations.

4 Section 29 of the Regulations is repealed.

5 Subsection 30(2) of the Regulations is replaced by the following:

Non-application — controlled drug or narcotic for veterinary use only

(2) These Regulations do not apply to a controlled drug or narcotic that is for veterinary use only.

6 Subsection 31(3) of the Regulations is replaced by the following:

Timing of payment

(3) Subject to subsection (4), the fee is payable at the time the application for the issuance or renewal of a dealer’s licence is submitted under section 11 or 15, respectively, of the Controlled Substances Regulations.

Coming into Force

7 These Regulations come into force on the day on which the Controlled Substances Regulations come into force, but if they are registered after that day, they come into force on the day on which they are registered.

N.B. The Regulatory Impact Analysis Statement for these Regulations appears following SOR/2025-242, Controlled Substances Regulations.